Blood biomarkers for the non-invasive diagnosis of endometriosis
Open accessThe DOI matches its Crossref record; 390 of the 390 references it cites were found in a registry or an index.
Abstract
BACKGROUND: About 10% of reproductive-aged women suffer from endometriosis, a costly chronic disease causing pelvic pain and subfertility. Laparoscopy is the gold standard diagnostic test for endometriosis, but is expensive and carries surgical risks. Currently, there are no non-invasive or minimally invasive tests available in clinical practice to accurately diagnose endometriosis. Although other reviews have assessed the ability of blood tests to diagnose endometriosis, this is the first review to use Cochrane methods, providing an update on the rapidly expanding literature in this field. OBJECTIVES: To evaluate blood biomarkers as replacement tests for diagnostic surgery and as triage tests to inform decisions on surgery for endometriosis. Specific objectives include:1. To provide summary estimates of the diagnostic accuracy of blood biomarkers for the diagnosis of peritoneal, ovarian and deep infiltrating pelvic endometriosis, compared to surgical diagnosis as a reference standard.2. To assess the diagnostic utility of biomarkers that could differentiate ovarian endometrioma from other ovarian masses. SEARCH METHODS: We did not restrict the searches to particular study designs, language or publication dates. We searched CENTRAL to July 2015, MEDLINE and EMBASE to May 2015, as well as these databases to 20 April 2015: CINAHL, PsycINFO, Web of Science, LILACS, OAIster, TRIP, ClinicalTrials.gov, DARE and PubMed. SELECTION CRITERIA: We considered published, peer-reviewed, randomised controlled or cross-sectional studies of any size, including prospectively collected samples from any population of reproductive-aged women suspected of having one or more of the following target conditions: ovarian, peritoneal or deep infiltrating endometriosis (DIE). We included studies comparing the diagnostic test accuracy of one or more blood biomarkers with the findings of surgical visualisation of endometriotic lesions. DATA COLLECTION AND ANALYSIS: Two authors independently collected and performed a quality assessment of data from each study. For each diagnostic test, we classified the data as positive or negative for the surgical detection of endometriosis, and we calculated sensitivity and specificity estimates. We used the bivariate model to obtain pooled estimates of sensitivity and specificity whenever sufficient datasets were available. The predetermined criteria for a clinically useful blood test to replace diagnostic surgery were a sensitivity of 0.94 and a specificity of 0.79 to detect endometriosis. We set the criteria for triage tests at a sensitivity of ≥ 0.95 and a specificity of ≥ 0.50, which 'rules out' the diagnosis with high accuracy if there is a negative test result (SnOUT test), or a sensitivity of ≥ 0.50 and a specificity of ≥ 0.95, which 'rules in' the diagnosis with high accuracy if there is a positive result (SpIN test). MAIN RESULTS: We included 141 studies that involved 15,141 participants and evaluated 122 blood biomarkers. All the studies were of poor methodological quality. Studies evaluated the blood biomarkers either in a specific phase of the menstrual cycle or irrespective of the cycle phase, and they tested for them in serum, plasma or whole blood. Included women were a selected population with a high frequency of endometriosis (10% to 85%), in which surgery was indicated for endometriosis, infertility work-up or ovarian mass. Seventy studies evaluated the diagnostic performance of 47 blood biomarkers for endometriosis (44 single-marker tests and 30 combined tests of two to six blood biomarkers). These were angiogenesis/growth factors, apoptosis markers, cell adhesion molecules, high-throughput markers, hormonal markers, immune system/inflammatory markers, oxidative stress markers, microRNAs, tumour markers and other proteins. Most of these biomarkers were assessed in small individual studies, often using different cut-off thresholds, and we could only perform meta-analyses on the data sets for anti-endometrial antibodies, interleukin-6 (IL-6), cancer antigen-19.9 (CA-19.9) and CA-125. Diagnostic estimates varied significantly between studies for each of these biomarkers, and CA-125 was the only marker with sufficient data to reliably assess sources of heterogeneity.The mean sensitivities and specificities of anti-endometrial antibodies (4 studies, 759 women) were 0.81 (95% confidence interval (CI) 0.76 to 0.87) and 0.75 (95% CI 0.46 to 1.00). For IL-6, with a cut-off value of > 1.90 to 2.00 pg/ml (3 studies, 309 women), sensitivity was 0.63 (95% CI 0.52 to 0.75) and specificity was 0.69 (95% CI 0.57 to 0.82). For CA-19.9, with a cut-off value of > 37.0 IU/ml (3 studies, 330 women), sensitivity was 0.36 (95% CI 0.26 to 0.45) and specificity was 0.87 (95% CI 0.75 to 0.99).Studies assessed CA-125 at different thresholds, demonstrating the following mean sensitivities and specificities: for cut-off > 10.0 to 14.7 U/ml: 0.70 (95% CI 0.63 to 0.77) and 0.64 (95% CI 0.47 to 0.82); for cut-off >
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Self-citationHao (2015) · doi:10.1002/14651858 · Cited by 11,321
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Self-citationTowards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · BMJ · doi:10.1136/bmj.326.7379.41 · Cited by 3,215
Self-citationTowards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · Radiology · doi:10.1148/radiol.2261021292 · Cited by 3,215
Self-citationGiudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Revised American Society for Reproductive Medicine classification of endometriosis: 1996
American Society for Reproductive Medicine (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81391-x · Cited by 3,018
Sampson, J. A. (1927) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30003-x · Cited by 2,334
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211
ESHRE guideline for the diagnosis and treatment of endometriosis
Kennedy, S., Bergqvist, A., Chapron, C., D’Hooghe, T., Dunselman, G., Greb, R., Hummelshoj, L., Prentice, A., & Saridogan, E. (2005) · Human Reproduction · doi:10.1093/humrep/dei135 · Cited by 1,584
Research works printed but not linked: 62
- Calienno, 2008, MCP-1 and IL-8 in serum and ectopic endometrium in women with endometriosis, Italian Journal of Gynaecology and Obstetrics, 20, 12
- Ferreira, 1994, Assessement of serum concentration CA-125 in the diagnosis of endometriosis, Jornal Brasileiro de Gynecologia, 104, 311
- Franchi, 1993, Use of serum CA125 measurement in patients with endometriosis, Italian Journal of Gynaecology and Obstetrics, 5, 149
- Goluda, 1998, The concentration of exfoliative adhesion molecules (ICAM-1 and E-Selectin) in serum and peritoneal fluid of women with endometriosis, Ginekologia Polska, 69, 1175
- Lamp, 2012, Survivin promoter polymorphisms and autoantibodies in endometriosis, Journal of Reproductive Immunology, 96, 95, 10.1016/j.jri.2012.10.001 · doi:10.1016/j.jri.2012.10.001
- Lin, 2005, Determination of interleukine-16 levels in peritoneal fluid and serum of women with endometriosis, Zhejiang Daxue Xuebao (Yixueban) [Journal of Zhejiang University (Medical Sciences)], 34, 260-2. Chinese
- Liu, 2009, Establishment of endometriosis diagnostic model using plasma protein profiling, Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics and Gynecology], 44, 601-4. Chinese
- Markham, 1997, Blood and peritoneal fluid concentrations of TNFalpha and RANTES in patients with and without endometriosis, Australian Journal of Medical Science, 18, 116
- Matveeva, 1990, Immunological studies of peripheral blood in patients with external genital endometriosis and infertility, Akusherstvo i Ginekologiia, 8, 48
- Szczepaska, 2001, Antizona and antisperm antibodies in women with endometriosis and/or infertility, Fertility & Sterility, 75, 97, 10.1016/S0015-0282(00)01667-8 · doi:10.1016/s0015-0282(00)01667-8
- Wei, 2005, Leptin levels and infertile patients with endometriosis, Zhongnan Daxue Xuebao (Yixue Ban) [Journal of Central South University (Medical Sciences)], 30, 487-8. Chinese
- Yang, 1994, Value of CA125 (carbon hydrate tumor-associated antigen) and endometrial antibodies for the detections of endometriosis, Zhonghua Fuchanke Zazhi [Chinese Journal of Obstetrics and Gynecology], 29, 147-149, 189. C
- Zhang, 2005, Measurements of interleukin-18 in peritoneal fluid and serum of patients with endometriosis, Zhongnan Daxue Xuebao (Yixue Ban) [Journal of Central South University (Medical Sciences)], 30, 731-2. Chinese
- Zhang, 2006, Soluble intercellular adhesion molecule 1 in serum and peritoneal fluid on patients with endometriosis, Wuhan Yike Daxue Xuebao (Yixueban) [Medical Journal of Wuhan University], 27, 97-9. Chinese
- Abdallah, 2006, Matrix metalloproteinase-9 activity in the plasma of patients after surgical resection of endometriomas, Fertility and Sterility, 85, 1847, 10.1016/j.fertnstert.2005.11.043 · doi:10.1016/j.fertnstert.2005.11.043
- Arjona Berral, 1996, Serum CA 125 and CA 19.9 levels in the diagnosis of patients with suspected endometriosis, Revista Espanola de Medicina Nuclear, 15, 71
- Barbieri, 1987, CA-125 and endometriosis, Contributions to Gynecology and Obstetrics, 16, 103, 10.1159/000414854 · doi:10.1159/000414854
- Basta, 2009, Differences in the blood serum levels of soluble HLA-G concentrations between the menstrual cycle phases and menopause in patients with ovarian endometriosis and uterine leiomyoma, Neuroendocrinology Letters, 30, 91
- Bianchi, 2003, Correlation between CA-125 marker with the presence and severity of pelvic endometriosis, Revista Medica de Chile, 131, 367
- Brinton, 1996, Endometriosis: identification by carbonic anhydrase autoantibodies and clinical features, Annals of Clinical and Laboratory Science, 26, 409
- Cai, 2005, Changes of serum epithelial neutrophil-activating peptide-78 in patients with endometriosis, Di 1 Junyi Daxue Xuebao [Academic Journal of the First Medical College of PLA], 25, 464-5. Chinese
- Dawood, 1988, Plasma and peritoneal fluid levels of CA 125 in women with endometriosis, American Journal of Obstetrics and Gynecology, 159, 1526, 10.1016/0002-9378(88)90588-1 · doi:10.1016/0002-9378(88)90588-1
- Ejzenberg, 2013, Measurement of serum and peritoneal levels of amyloid protein A and their importance in the diagnosis of pelvic endometriosis, Journal of Reproductive Medicine, 58, 411
- Galo, 2005, TNF-alpha serum levels in women with endometriosis: Prospective clinical study, Ceska Gynekologie, 70, 286
- Gebel, 1995, Differential expression of VLA beta 1 (CD29) on monocytes from patients with endometriosis, American Journal of Reproductive Immunology, 34, 317, 10.1111/j.1600-0897.1995.tb00958.x · doi:10.1111/j.1600-0897.1995.tb00958.x
- Gunev, 1981, FSH, LH, estradiol and testosterone studies of the blood serum in endometriosis externa, Akusherstvo i Ginekologiia, 20, 312
- He, 1993, Prolactin secretion in patients with endometriosis and its relationship to luteal phase defect and infertility, Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics and Gynecology], 28, 14-7. Chinese
- Hompes, 1996, Serum CA-125 concentrations during midfollicular phase, a clinically useful and reproducible marker in diagnosis of advanced endometriosis, Clinical Chemistry, 42, 1871, 10.1093/clinchem/42.11.1871 · doi:10.1093/clinchem/42.11.1871
- Hrycek, 1996, Selected immunologic markers for evaluation of peripheral blood in patients with internal endometriosis, Wiadomosci lekarskie, 49, 10
- Jedryka, 2001, E-cadherin in the serum and the peritoneal fluid of women with endometriosis, Ginekologia Polska, 72, 418
- Kadija, 2012, The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis, International Journal of Gynecological Cancer, 22, 238, 10.1097/IGC.0b013e318234f852 · doi:10.1097/igc.0b013e318234f852
- Kobayashi, 1987, Usefulness of measurement of serum CA125 levels in diagnosing and treating endometriosis, Nippon Sanka Fujinka Gakkai Zasshi - Acta Obstetrica et Gynaecologica Japonica, 39, 1054
- Kondera-Anasz, 2004, Concentrations of neopterin and interleukin-10 in peritoneal fluid and in serum of women with endometriosis, Pteridines, 15, 20, 10.1515/pteridines.2004.15.1.20 · DOI
- Kralickova, 2007, Association of the leukemia inhibitory factor gene mutation and the antiphospholipid antibodies in the peripheral blood of infertile women, Folia Microbiologica, 52, 543, 10.1007/BF02932117 · doi:10.1007/bf02932117
- Leggieri, 2014, Is HE4 a useful endometrioma marker?, European Journal of Gynaecological Oncology, 35, 438
- Leng, 2002, Serum levels of soluble intercellular molecule 1 (sICAM-1) in endometriosis, Zhonghua Yixue Zazhi [Chinese Medical Journal], 82, 189-90. Chinese
- Li, 2000, Evaluation of tumor necrosis factor-alpha and interleukin-6 levels in serum and peritoneal fluid of patients with endometriosis, Zhonghua Fuchanke Zazhi [Chinese Journal of Obstetrics and Gynecology], 35, 166-8. Chinese
- Liu, 2013, The expression and role of oxidative stress markers in the serum and follicular fluid of patients with endometriosis, Clinical and Experimental Obstetrics & Gynecology, 40, 372
- Luo, 2005, Evaluation of tumor necrosis factor-alpha and tumor necrosis factor-beta in serum of patients with endometriosis, Zhongnan Daxue Xuebao (Yixue Ban) [Journal of Central South University (Medical Sciences)], 30, 304-6. Chinese
- Markham, 1997, The measurement of tumour necrosis factor alpha in patients with endometriosis, Australian Journal of Medical Science, 18, 56
- Nalbanski, 2008, The use of biochemical markers in diagnosis of endometriosis, Akusherstvo i Ginekologiia, 47, 19
- Ota, 1990, Evaluation of autoantibody and CA125 in the diagnosis of endometriosis or adenomyosis, Medical Science Research, 18, 309
- Ota, 1991, Autoantibody sensitivity in the diagnosis of endometriosis and adenomyosis, Japanese Journal of Fertility and Sterility, 36, 799
- Ozasa, 1987, Progesterone increases serum CA-125 in endometriosis, Fertility and Sterility, 47, 699, 10.1016/S0015-0282(16)59125-0 · doi:10.1016/s0015-0282(16)59125-0
- Perwira I Comparison of TNF-alpha and IL-6 between the blood and peritoneal fluid in patients with endometriosis Thesis: Universitas Gadjah Mada, Yogyakarta 2009
- Ramos IML Podgaec S Evaluation of CA-125 and CD-23 soluble in patients with pelvic endometriosis Biblioteca Digitais de Teses e Dissertações da USP 2011 · DOI
- Szyllo, 2001, Evaluation of the generation of interleukin-10 by peripheral blood lymphocytes in women with endometriosis, Ginekologia Polska, 72, 437
- Takahashi, 1987, CA 125 antigen is an effective diagnostic for external endometriosis, Gynecologic and Obstetric Investigation, 23, 257, 10.1159/000298869 · doi:10.1159/000298869
- Takahashi, 1988, Clinical usefulness of determination of CA 125 levels in the serum and menstrual blood, Gynecologic and Obstetric Investigation, 26, 63, 10.1159/000293674 · doi:10.1159/000293674
- Tanaka, 2000, Anti-endometrial IgM autoantibodies in endometriotic patients: a preliminary study, Clinical and Experimental Obstetrics & Gynecology, 27, 133
- Tsao, 2007, Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis, Journal of Clinical Laboratory Analysis, 21, 193, 10.1002/jcla.20168 · DOI
- Wild, 1991, F(ab')2 segment is the active component of immunoglobulin G autoantibody generation in patients with endometriosis, Fertility and Sterility, 56, 900, 10.1016/S0015-0282(16)54662-7 · doi:10.1016/s0015-0282(16)54662-7
- Wild, 1992, Detection of antiendometrial antibodies in patients with endometriosis: methodological issues, Fertility and Sterility, 58, 518, 10.1016/S0015-0282(16)55255-8 · doi:10.1016/s0015-0282(16)55255-8
- Wojcik-Krowiranda, 2010, Usefulness of determination of CA125 concentration as a marker for ovarian tumours with special consideration of ovarian endometriotic cysts, Przeglad Menopauzalny, 9, 362
- Zhu, 2007, Measurement of CA125 in serum and ovarian cyst fluid of patients with endometriosis and its clinical significance, Xi'an Jiaotong Daxue Xuebao (Yexueban) [Journal of Xi'an Jiaotong University (Medical Sciences)], 28, 687-9. Chinese
- Adamson GD Endometriosis Fertility Index (EFI): the new validated endometriosis staging system Art and science of endometriosis. Proceedings of the Tenth World Congress on Endometriosis; 2008 March 11-14; Melbourne (Vic) 2008
- Bossuyt PM Leeflang MM Chapter 6: Developing Criteria for Including Studies. In: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 [updated September 2008]. The Cochrane Collaboration, 2008 Available from www.methods.cochrane.org/sdt/handbook-dta-reviews
- De Vet HCW Eisinga A Riphagen II Aertgeerts B Pewsner D Chapter 7: Searching for Studies. In: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 [updated September 2008]. The Cochrane Collaboration, 2008 Available from www.methods.cochrane.org/sdt/handbook-dta-reviews
- Matalliotakis, 2008, Suggested markers for the diagnosis of endometriosis, Current Women's Health Reviews, 4, 25, 10.2174/157340408783572042 · doi:10.2174/157340408783572042
- Segen, 2006, McGraw-Hill Concise Dictionary of Modern Medicine
- The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014
- Olendorf, 2011, The Gale Encyclopedia of Medicine (5 volume set)
Cited by
Zondervan, K. T., Becker, C. M., & Missmer, S. A. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1810764 · Cited by 2,249
ESHRE guideline: endometriosis
Becker, C. M., Bokor, A., Heikinheimo, O., Horne, A., Jansen, F., Kiesel, L., King, K., Kvaskoff, M., Nap, A., Petersen, K., et al. (2022) · Human Reproduction Open · doi:10.1093/hropen/hoac009 · Cited by 1,712
“…in endometrial tissue, blood, menstrual or uterine fluids to diagnose endometriosis (Mol et al. , 1998; May et al. , 2010; May et al. , 2011; Liu et al. , 2015; Cosar et al. , 2016; Gupta et al. , 2016; Hirsch et al. , 2016; Nisenblat et al. , 2016a; Vanhie et al. , 2019; Moustafa et al. , 2020).”
Endometriosis is a chronic systemic disease: Clinical challenges and novel innovations
Taylor, H. S., Kotlyar, A. M., & Flores, V. A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00389-5 · Cited by 1,425
Zondervan, K. T., Becker, C. M., Koga, K., Missmer, S. A., Taylor, R. N., & Viganò, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0008-5 · Cited by 1,257
Endometriosis: Etiology, pathobiology, and therapeutic prospects
Saunders, P. T. K., & Horne, A. W. (2021) · Cell · doi:10.1016/j.cell.2021.04.041 · Cited by 961
Endometriosis: Epidemiology, Diagnosis and Clinical Management
Parasar, P., Ozcan, P., & Terry, K. L. (2017) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-017-0187-1 · Cited by 753
Pathophysiology, diagnosis, and management of endometriosis
Horne, A. W., & Missmer, S. A. (2022) · BMJ · doi:10.1136/bmj-2022-070750 · Cited by 661
Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
Dochez, V., Caillon, H., Vaucel, E., Dimet, J., Winer, N., & Ducarme, G. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0503-7 · Cited by 577
Smolarz, B., Szyłło, K., & Romanowicz, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910554 · Cited by 560
Menstruation: science and society
Critchley, H. O. D., Babayev, E., Bulun, S. E., Clark, S., Garcia-Grau, I., Gregersen, P. K., Kilcoyne, A., Kim, J.-Y. J., Lavender, M., Marsh, E. E., et al. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.06.004 · Cited by 448
The association between endometriosis and autoimmune diseases: a systematic review and meta-analysis
Shigesi, N., Kvaskoff, M., Kirtley, S., Feng, Q., Fang, H., Knight, J. C., Missmer, S. A., Rahmioglu, N., Zondervan, K. T., & Becker, C. M. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz014 · Cited by 382
Assessing research gaps and unmet needs in endometriosis
As-Sanie, S., Black, R., Giudice, L. C., Gray Valbrun, T., Gupta, J., Jones, B., Laufer, M. R., Milspaw, A. T., Missmer, S. A., Norman, A., et al. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.02.033 · Cited by 340
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Lee, T., Teng, T. Z. J., & Shelat, V. G. (2020) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v12.i12.468 · Cited by 293
Estrogen-progestins and progestins for the management of endometriosis
Vercellini, P., Buggio, L., Berlanda, N., Barbara, G., Somigliana, E., & Bosari, S. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.022 · Cited by 243
Guo, S.-W. (2018) · Human Reproduction · doi:10.1093/humrep/dey015 · Cited by 116
Polymorphisms and endometriosis: A systematic review and meta-analyses
Méar, L., Herr, M., Fauconnier, A., Pineau, C., & Vialard, F. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmz034 · Cited by 85
Diagnostic Significance of Selected Serum Inflammatory Markers in Women with Advanced Endometriosis
Kokot, I., Piwowar, A., Jędryka, M., Sołkiewicz, K., & Kratz, E. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052295 · Cited by 76
“[55] in a metaanalysis assessed CA 125 at different thresholds, but the cut-off interval of >16.”
BackgroundMethodNew biomarkers in endometriosis
(2019) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.12.002 · Cited by 72
Validation of a salivary miRNA signature of endometriosis—interim data
Bendifallah, S., Dabi, Y., Suisse, S., Delbos, L., Spiers, A., Poilblanc, M., Golfier, F., Jornea, L., Bouteiller, D., Fernandez, H., et al. (2023) · NEJM Evidence · doi:10.1056/evidoa2200282 · Cited by 71
When more is not better: 10 ‘don’ts’ in endometriosis management. An ETIC* position statement
Club, E. E. T. I., Alio, L., Angioni, S., Arena, S., Bartiromo, L., Bergamini, V, Berlanda, N., Bonin, C., Busacca, M., Candiani, M., et al. (2019) · Human Reproduction Open · doi:10.1093/hropen/hoz009 · Cited by 64
MicroRNome analysis generates a blood-based signature for endometriosis
Bendifallah, S., Dabi, Y., Suisse, S., Jornea, L., Bouteiller, D., Touboul, C., Puchar, A., & Daraï, E. (2022) · Scientific Reports · doi:10.1038/s41598-022-07771-7 · Cited by 61
An integrated multi-tissue approach for endometriosis candidate biomarkers: a systematic review
Brulport, A., Bourdon, M., Vaiman, D., Drouet, C., Pocate-Cheriet, K., Bouzid, K., Marcellin, L., Santulli, P., Abo, C., Jeljeli, M., et al. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-023-01181-8 · Cited by 52
Burghaus, S., Drazic, P., Wölfler, M., Mechsner, S., Zeppernick, M., Meinhold‐Heerlein, I., Mueller, M. D., Rothmund, R., Vigano, P., Becker, C. M., et al. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15062 · Cited by 38
Management of endometriosis: Toward value-based, cost-effective, affordable care
Vercellini, P., Facchin, F., Buggio, L., Barbara, G., Berlanda, N., Frattaruolo, M. P., & Somigliana, E. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.07.011 · Cited by 36
Monnaka, V. U., Hernandes, C., Heller, D., & Podgaec, S. (2021) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2021rw5704 · Cited by 33
Sasamoto, N., DePari, M., Vitonis, A. F., Laufer, M. R., Missmer, S. A., Shafrir, A. L., & Terry, K. L. (2020) · PLOS ONE · doi:10.1371/journal.pone.0238043 · Cited by 31
Crestani, A., Arfi, A., Ploteau, S., Breban, M., Boudy, A.-S., Bendifallah, S., Ferrier, C., & Darai, E. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa023 · Cited by 28
Schoeman, E. M., Bringans, S., Peters, K., Casey, T., Andronis, C., Chen, L., Duong, M., Girling, J. E., Healey, M., Boughton, B. A., et al. (2025) · Human Reproduction · doi:10.1093/humrep/deae278 · Cited by 27
Nezhat, C. R., Oskotsky, T. T., Robinson, J. F., Fisher, S. J., Tsuei, A., Liu, B., Irwin, J. C., Gaudilliere, B., Sirota, M., Stevenson, D. K., et al. (2025) · npj Women s Health · doi:10.1038/s44294-024-00052-w · Cited by 25
Gao, Y., Shen, M., Ma, X., Li, J., Wang, B., Wang, J., & Tian, J. (2019) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2019.04.004 · Cited by 18
Seckin, B., Ates, M. C., Kirbas, A., & Yesilyurt, H. (2021) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2018-0078 · Cited by 18
Circulating Endometrial Cells: A New Source of Information on Endometriosis Dynamics
Pospisilova, E., Kiss, I., Souckova, H., Tomes, P., Spicka, J., Matkowski, R., Jedryka, M., Ferrero, S., Bobek, V., & Kolostova, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111938 · Cited by 17
A short anogenital distance on MRI is a marker of endometriosis
Crestani, A., Abdel Wahab, C., Arfi, A., Ploteau, S., Kolanska, K., Breban, M., Bendifallah, S., Ferrier, C., & Darai, E. (2021) · Human Reproduction Open · doi:10.1093/hropen/hoab003 · Cited by 15
The Impact of Laparoscopic Surgery on Fertility Outcomes in Patients with Minimal/Mild Endometriosis
Grigoriadis, G., Roman, H., Gkrozou, F., & Daniilidis, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164817 · Cited by 10
“A Cochrane review identified no reliable biomarkers in the blood for clinical use in the diagnosis of endometriosis [105], with similar conclusions drawn for urinary biomarkers [106].”
The Impact of Laparoscopic Surgery on Fertility Outcomes in Patients with Minimal/Mild Endometriosis
Grigoriadis, G., & Daniilidis, A. (2024) · doi:10.20944/preprints202407.0446.v1 · Cited by 10
Rectus Abdominis Muscle Endometriosis: A Unique Case Report with a Literature Review
Turčić, M., Matušan Ilijaš, K., Rajković Molek, K., & Valković Zujić, P. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47010047 · Cited by 6
“The five-year survival rate for malignant AWE ranges from 40% to 80%, with better outcomes for endometrioid adenocarcinomas [64,66,69,70].”
Influential
Metadata
- Authors
- Nisenblat, V., Bossuyt, P. M., Shaikh, R., Farquhar, C., Jordan, V., Scheffers, C. S., Mol, B. W. J., Johnson, N., & Hull, M. L.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2016-05-01
- Volume
- 2016
- Issue
- 5
- Pages
- CD012179-CD012179
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2410974791
- Cited by
- 376
- References
- 390
- FWCI
- 31.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.